Large Cell Immunoblastic Lymphoma
Links shared publicly online about this topic
BREAST IMPLANTS and ALAC ANAPLASTIC LARGE CELL LYMPHOMA
cosmeticsurgery-news.com — “BREAST IMPLANTS and ALAC ANAPLASTIC LARGE CELL LYMPHOMA” View full resource at cosmeticsurgery-news.com
Most Recently Shared on February 7, 2011 at 7:27 pm By:
Kevin M. Johnson, MD Physician, Doctor, and Surgeon
FDA warns about breast implants and rare form of cancer. http://cosmeticsurgery-news.com/article3090.html
Adcetris Approved for Hodgkin lymphoma and Systemic Anaplastic Large Cell Lymphoma - MPR
empr.com — “The FDA approved Adcetris (brentuximab vedotin; Seattle Genetics) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).” View full resource at empr.com
Most Recently Shared on August 22, 2011 at 2:10 pm By:
Adcetris Approved for Hodgkin lymphoma and Systemic Anaplastic Large Cell Lymphoma http://ow.ly/69lQM #lymphoma #adcetris
Large B-Cell Lymphoma Prognosis-New large B-cell lymphoma prognosis research...
newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.” View full resource at newsrx.com
Most Recently Shared on December 18, 2009 at 2:01 pm By:
NewsRx Medical News Health News
New large B-cell lymphoma prognosis research from St. Vincent's Hospital, Department of...http://bit.ly/5BhrjO
Adcetris (Brentuximab Vedotin) Approved For Hodgkin Lymphoma And Systemic Anaplastic Large Cell Lymphoma - FDA
medicalnewstoday.com — “The FDA has approved brentuximab vedotin, brand name Adcetris, for the treatment of HL (Hodgkin lymphoma) and ALCL (systemic anaplastic large cell lymphoma). Adcetris consists of a drug and an ant” View full resource at medicalnewstoday.com
Most Recently Shared on August 19, 2011 at 9:05 pm By:
Adcetris (Brentuximab Vedotin) Approved For Hodgkin Lymphoma And Systemic Anaplastic Large Cell Lymphoma - FDA http://mnt.to/3Z5F
Anaplastic Large Cell Lymphoma and Breast Implants - Suresh Koneru, MD
drkoneru.posterous.com — “Anaplastic Large Cell Lymphoma and Breast Implants - Suresh Koneru, MD” View full resource at drkoneru.posterous.com
Most Recently Shared on January 31, 2011 at 4:31 am By:
Suresh Koneru, MD Physician, Doctor, Surgeon, and Plastic Surgeon
Anaplastic Large Cell Lymphoma and Breast Implants http://post.ly/1YTTI
BLA Submitted for Brentuximab Vedotin for Hodgkin and Anaplastic Large Cell Lymphomas - ONA
oncologynurseadvisor.com — “Seattle Genetics announced that it has submitted a Biologics License Application (BLA) to the FDA for the use of brentuximab vedotin (SGN-35) to treat relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 1, 2011 at 5:25 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
BLA Submitted for Brentuximab Vedotin for Hodgkin and Anaplastic Large Cell Lymphomas http://goo.gl/fb/6ZBhe
Oncology Medical News about Lymphoma, Large-Cell, Anaplastic
mdlinx.com — “Cutaneous intravascular anaplastic large cell lymphoma” View full resource at mdlinx.com
Most Recently Shared on March 24, 2010 at 10:00 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cutaneous intravascular anaplastic large cell lymphoma: Journal of Cutaneous Pathology http://bit.ly/bPfQ7K #HemeOnc
Treatment of Large Cell Lymphoma: R-CHOP and Beyond
onclive.com — “The treatment of diffuse large B-cell lymphoma continues to evolve, as researchers seek to improve upon the current standard of care.” View full resource at onclive.com
Most Recently Shared on January 31, 2012 at 10:51 pm By:
The treatment of DLBCL continues to evolve, as researchers seek to improve upon the current standard of care http://t.co/5oCn7i0W
BLA Submitted for Brentuximab Vedotin for Hodgkin and Anaplastic Large Cell Lymphomas - MPR
empr.com — “Seattle Genetics announced that it has submitted a Biologics License Application (BLA) to the FDA for the use of brentuximab vedotin (SGN-35) to treat relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.” View full resource at empr.com
Most Recently Shared on March 1, 2011 at 5:17 pm By:
MPR News: BLA Submitted for Brentuximab Vedotin for Hodgkin and Anaplastic Large Cell Lymphomas: Seattle Genetic... http://bit.ly/eZo3Yj
Diffuse Large B-Cell Lymphoma with Calf Muscle Localization
hindawi.com — “Although diffuse large B-cell lymphoma (DLBCL) usually occurs in the lymph nodes, approximately 30–40% of the time it can have an extranodal site of involvement and it can arise in nearly every body site such as intestine, bone, breast, liver, skin, lung, and central nervous system. Muscle involvement of DLBCL is especially uncommon, comprising 0.5% of extranodal NHL. We report a case of a 72-year-old man with extranodal DLBCL of a unique manifestation in the calf muscle, involving predominantly” View full resource at hindawi.com
Most Recently Shared on July 9, 2011 at 11:23 pm By:
Diffuse Large B-Cell Lymphoma with Calf Muscle Localization: We report a case of a 72-year-old man with extranod... http://bit.ly/ng4HWW
Oncology Medical News about Lymphoma Lymphoma, Large B-Cell, Diffuse Prognosis
mdlinx.com — “Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab” View full resource at mdlinx.com
Most Recently Shared on June 1, 2010 at 8:16 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma tre... http://bit.ly/bkklxH #oncology
Cutaneous CD30+ (Ki-1) Anaplastic Large-Cell Lymphoma: eMedicine Dermatology
emedicine.medscape.com — “Overview: CD30+ lymphoproliferative disorders include a wide spectrum of disease with lymphomatoid papulosis at the benign end of the spectrum and cutaneous CD30+ anaplastic large-cell lymphomas (ALCLs) at the malignant end. Borderline lesions lie somewhere in between.” View full resource at emedicine.medscape.com
Most Recently Shared on March 2, 2010 at 8:42 pm By:
Medscape Dermatology Health Site
Cutaneous CD30+ anaplastic large-cell lymphoma article updated for 2010: http://bit.ly/c5Gqmy
Search of: anaplastic AND "large cell" AND lymphoma - Results on Map - ClinicalTrials.gov
clinicaltrials.gov — “Search of: anaplastic AND "large cell" AND lymphoma - Results on Map - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 29, 2009 at 2:59 pm By:
Australia. Clinical trials now recruiting for Anaplastic Large Cell Lymphoma. Click on State. No trials in NZ. http://bit.ly/DyUvb
Search of: anaplastic AND "large cell" AND lymphoma - Results on Map - ClinicalTrials.gov
clinicaltrials.gov — “Search of: anaplastic AND "large cell" AND lymphoma - Results on Map - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 29, 2009 at 2:56 pm By:
CANADA Clinical Trials now recruiting for Anaplastic Large Cell Lymphoma. Click on province to see trials in your area. http://bit.ly/OMz6R
Genmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma
medicalnewstoday.com — “Genmab A/S (OMX: GEN) announced today top-line interim results from an initial Phase II single arm open label studyof ofatumumab to evaluate the treatment of relapsed Diffuse Large B-CellLympho” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2010 at 2:00 pm By:
Genmab Announces Top-Line Interim Results For Ofatumumab In Diffuse Large B-Cell Lymphoma http://mnt.to/3HdC #lymphoma #leukemia
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Kevin M. Johnson, MD
Cosmetic Surgeon Caring physician Teacher
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
NewsRx Medical News
Advertisement
